Header cover image

Global Healthcare Undervalued over 20% based on DCF

UPDATED Dec 06, 2023

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

196 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
301239Chengdu Bright Eye HospitalCNÂ¥96.73-4.7%45.1%CNÂ¥14.9bn/aPE59.4xE21.4%0.1%
NUVANuVasiveUS$39.751.5%-8.3%US$2.1bUS$49.00PE73.3xE46.2%n/a
ICUIICU MedicalUS$86.29-1.7%-43.4%US$2.1bUS$153.50PB1xE68.0%n/a
28China National Accord MedicinesCNÂ¥28.73-6.4%-3.0%CNÂ¥14.9bCNÂ¥36.44PE9.8xE8.3%2.1%
6951JEOLJPÂ¥5,914.000.9%42.5%JPÂ¥302.4bJPÂ¥6,936.00PE16.7xE10.0%1.3%
853MicroPort ScientificHK$8.54-31.8%-57.7%HK$15.9bHK$18.87PS2.2xE35.3%n/a
ANNAnsellAU$24.262.3%-13.7%AU$3.0bAU$24.51PE13.3xE4.4%2.8%
300171Tofflon Science and Technology GroupCNÂ¥18.08-3.5%-24.6%CNÂ¥13.8bCNÂ¥25.00PE16.7xE18.2%1.8%
COPCompuGroup Medical SE KGaA€33.54-10.9%-10.0%€1.8b€54.91PE23.2xE22.0%1.5%
OMIOwens & MinorUS$22.1711.5%5.2%US$1.7bUS$19.40PB1.9xE127.9%0%
TVTYTivity HealthUS$32.500.4%22.2%US$1.6bUS$30.17PE18.4xE12.5%n/a
2273Gushengtang HoldingsHK$48.70-4.0%2.3%HK$12.3bHK$64.16PE49.3xE30.1%n/a
OMCLOmnicellUS$33.771.2%-29.9%US$1.5bUS$39.33PS1.3xE122.5%n/a
VIVOMeridian BioscienceUS$33.970.06%54.3%US$1.5bUS$34.00PE35.2xn/a0%
STAASTAAR SurgicalUS$30.60-2.4%-50.0%US$1.5bUS$46.33PE76.8xE31.5%n/a
8129Toho HoldingsJPÂ¥3,315.002.6%62.4%JPÂ¥214.9bJPÂ¥2,940.00PE11.4xE-6.3%1.0%
ADUSAddus HomeCareUS$90.093.3%-15.1%US$1.4bUS$111.33PE25xE13.4%n/a
688389Shenzhen Lifotronic TechnologyCNÂ¥23.97-2.1%23.4%CNÂ¥10.2bCNÂ¥29.00PE33.7xE28.5%1.0%
TOPGLOVTop Glove Corporation BhdRM0.810.6%1.2%RM6.6bn/aPS2.9xE110.0%0%
7716NakanishiJPÂ¥2,370.00-1.2%-14.3%JPÂ¥205.6bJPÂ¥3,926.67PE8.2xE-7.9%2.2%
3360Ship Healthcare HoldingsJPÂ¥2,111.001.1%-20.0%JPÂ¥203.9bJPÂ¥2,667.50PE17.2xE10.9%2.0%
MDRXVeradigmUS$12.539.1%-31.6%US$1.4bUS$18.40PE11.8xE-40.3%n/a
CVSGCVS GroupUK£15.151.5%-27.2%UK£1.1bUK£23.02PE25.8xE13.6%0.5%
SUMSummerset Group HoldingsNZ$9.26-0.5%-3.1%NZ$2.2bNZ$12.40PE8.1xE19.4%2.4%
Page 2 of 9